Nathan Weinstein

Stock Analyst at Aegis Capital

(0.26)
# 4,339
Out of 5,031 analysts
61
Total ratings
13.33%
Success rate
-26.26%
Average return

Stocks Rated by Nathan Weinstein

Evogene
Sep 12, 2022
Maintains: Buy
Price Target: $100$80
Current: $1.25
Upside: +6,300.00%
DarioHealth
Aug 18, 2022
Maintains: Buy
Price Target: $400$300
Current: $13.24
Upside: +2,165.86%
VolitionRx
Aug 15, 2022
Maintains: Buy
Price Target: $9$6
Current: $0.44
Upside: +1,250.74%
Immunic
Aug 8, 2022
Maintains: Buy
Price Target: $40$35
Current: $0.80
Upside: +4,273.36%
Stereotaxis
Jul 12, 2022
Initiates: Buy
Price Target: $6
Current: $2.99
Upside: +100.67%
Oramed Pharmaceuticals
May 16, 2022
Maintains: Buy
Price Target: $35$30
Current: $2.24
Upside: +1,239.29%
Trevi Therapeutics
Mar 29, 2022
Initiates: Buy
Price Target: $10
Current: $10.36
Upside: -3.47%
MediWound
Mar 21, 2022
Maintains: Buy
Price Target: $63$49
Current: $18.80
Upside: +160.71%
Enveric Biosciences
Mar 8, 2022
Downgrades: Hold
Price Target: $5,250$150
Current: $0.76
Upside: +19,660.24%
Cingulate
Jan 11, 2022
Initiates: Buy
Price Target: $2,160
Current: $3.70
Upside: +58,278.38%
Initiates: Buy
Price Target: $120
Current: $3.32
Upside: +3,514.46%
Maintains: Buy
Price Target: $9$10
Current: $1.10
Upside: +809.09%
Maintains: Buy
Price Target: $180$160
Current: $101.52
Upside: +57.60%
Maintains: Buy
Price Target: $60$56
Current: $34.69
Upside: +61.43%
Maintains: Buy
Price Target: $26$27
Current: $6.45
Upside: +318.60%
Maintains: Buy
Price Target: $40$35
Current: $0.75
Upside: +4,538.22%
Initiates: Buy
Price Target: $12
Current: $2.35
Upside: +410.64%
Initiates: Buy
Price Target: $75
Current: $9.49
Upside: +690.31%
Maintains: Buy
Price Target: $104$88
Current: $2.98
Upside: +2,853.02%
Initiates: Buy
Price Target: $180
Current: $4.05
Upside: +4,344.44%
Maintains: Buy
Price Target: $195$135
Current: $4.61
Upside: +2,828.42%
Initiates: Buy
Price Target: $14
Current: $6.06
Upside: +131.02%
Maintains: Buy
Price Target: $180$220
Current: $19.64
Upside: +1,020.16%
Initiates: Buy
Price Target: $8.5
Current: $4.10
Upside: +107.32%